Abstract:Background: This study sought to analyze the clinical characteristics, biochemical metabolic indications, treatment results, and genetic spectrum of cerebral creatine deficiency syndrome (CCDS), estimate the prevalence of CCDS in Chinese children and provide a reference to guide clinical practice. Methods: We performed a retrospective cohort study of 3,568 children with developmental delay at Children's Hospital of Fudan University over a 6-year period (January 2017-December 2022). Metabolites in the blood/urine were detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS), and genetic testing was performed by next-generation sequencing (NGS). The patients with suspected CCDS were ultimately diagnosed by magnetic resonance spectroscopy (MRS). The patients were then treated and followed up. All the reported cases of CCDS, their gene mutations, and treatment results in China were summarized. Results: Ultimately, 14 patients were diagnosed with CCDS. The age of onset was between 1-2 years. All the patients had developmental delay, 9 had epilepsy, and 8 had movement or behavioral disorders. A total of 17 genetic variants were identified, including 6 novel variants. c.403G>A, c.491dupG of the guanidinoacetate methyltransferase (GAMT) gene had a relatively high frequency. After treatment, patients with GAMT deficiency showed obvious improvements, and brain creatine (Cr) levels recovered to 50-80% of normal, 1 patient achieved normal neurodevelopment, and 3 patients became epilepsy free; however, 6 male patients with X-linked creatine transporter gene (SLC6A8) variants received Cr for 3-6 months with no effect, and 2 patients received combined therapy with few improvements. Conclusions: The prevalence of CCDS is similar to 0.39% in Chinese children with developmental delay. A low-protein diet, Cr and, ornithine were useful for patients with GAMT deficiency. Male patients with SLC6A8 deficiency showed only limited improvement on combined therapy.

A simple screening method using ion chromatography for the diagnosis of cerebral creatine deficiency syndromes

Laboratory Diagnosis of Cerebral Creatine Deficiency Syndromes by Determining Creatine and Guanidinoacetate in Plasma and Urine

Colorimetric Detection of Citric Acid As the Biomarker for Urolithiasis Based on Sodium Dodecylsulfate-Agnps with a Portable CD-spectrometer.

Biochemical, molecular, and clinical diagnoses of patients with cerebral creatine deficiency syndromes.

Fourteen Cases of Cerebral Creatine Deficiency Syndrome in Children: a Cohort Study in China.

1H MR spectroscopy as a diagnostic tool for cerebral creatine deficiency

Diagnosis of Creatine Metabolism Disorders by Determining Creatine and Guanidinoacetate in Plasma and Urine.

Simultaneous determination of N(1)-methylnicotinamide, L-carnitine, and creatinine in human plasma and urine by liquid chromatography with mass spectrometry for assessing the activities of multiple renal cationic transporters

A Simple Method for Rapid Screening and Diagnosis of Common Organic Acidemias: Quantitative Detection of Serum and Urine Organic Acid Profiles Based on Liquid Chromatography-Tandem Mass Spectrometry

Simultaneous Determination of L-Citrulline and L-Arginine in Plasma by High Performance Liquid Chromatography.

Identification of novel variations in SLC6A8 and GAMT genes causing cerebral creatine deficiency syndrome

[Genetic Analysis and Treatment for an Infant with Cerebral Creatine Deficiency Syndrome Type 2].

Screening for creatine transporter deficiency in autism spectrum disorder: a pilot study

Diagnosis of glutaric aciduria type 1 by measuring 3-hydroxyglutaric acid in dried urine spots by liquid chromatography tandem mass spectrometry

Enzymatic assay of creatinine in serum and urine with creatinine iminohydrolase coupled glutamate dehydrogenase

Quantification of N-acetyl-l-aspartate in dried blood spots: A simple and fast LC-MS/MS neonatal screening method for the diagnosis of Canavan disease

Quantification of tissue creatine content using capillary electrophoresis

New Screening Cutoff Values for Detection of Aldosteronoma Examined by Lc-ms/ms and A Newly Developed Non-competitive Chemiluminescent Enzyme Immunoassay

Pilot Study on Neonatal Screening for Methylmalonic Acidemia Caused by Defects in the Adenosylcobalamin Synthesis Pathway and Homocystinuria Caused by Defects in Homocysteine Remethylation

Control of the quality of creatine sports supplements using a validated LC method with UV detection

A sensitive liquid chromatography−tandem mass spectrometry method for determination biomarkers of monoamine neurotransmitter disorders in cerebrospinal fluid